Elicio Therapeutics, Inc.ELTXNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
4.53%
↑ 115% above average
Average (23q)
-29.81%
Historical baseline
Range
High:194.82%
Low:-576.40%
Volatility
-2586.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 4.53% |
| Q2 2025 | 5.78% |
| Q1 2025 | 19.96% |
| Q4 2024 | 25.66% |
| Q3 2024 | -160.59% |
| Q2 2024 | 38.88% |
| Q1 2024 | -32.16% |
| Q4 2023 | 16.03% |
| Q3 2023 | -41.00% |
| Q2 2023 | 5.85% |
| Q1 2023 | -20.72% |
| Q4 2022 | 7.60% |
| Q3 2022 | 1.38% |
| Q2 2022 | 48.74% |
| Q1 2022 | -195.63% |
| Q4 2021 | 194.82% |
| Q3 2021 | 8.01% |
| Q2 2021 | -175.75% |
| Q1 2021 | 78.56% |
| Q4 2020 | -63.42% |
| Q3 2020 | 13.14% |
| Q2 2020 | -576.40% |
| Q1 2020 | 81.22% |
| Q4 2019 | 0.00% |